HOME >> MEDICINE >> NEWS
Benefits Of New Diet Drug Don't Outweigh Risks

ITHACA, N.Y. -- Don't bother with the hot new diet pill Redux -- the benefits don't outweigh the risks, according to a Cornell University nutritionist who has examined the 40 studies on long-term use of the diet pill. "People do lose weight more easily with Redux (d-fenfluramine) than with a placebo, but the advantage of taking the medication over a placebo after a year is less than 5-and-a-half pounds," said David Levitsky, professor of nutritional sciences and of psychology in the Division of Nutritional Sciences and Department of Psychology at Cornell and a nationally known expert on the control of obesity.

That amount of weight lost after one year of taking the drug daily rather than a placebo is equivalent to a 62-calorie difference a day, roughly the amount of calories in a medium-sized cookie or apple, or the amount burned by walking for a half-hour and making other small changes in daily motor activity. After one year, there is no indication that any further weight loss can be achieved by the medication alone, Levitsky said.

Until recently patients were prescribed appetite suppressing drugs such as Redux for no longer than 12 weeks to help them stick to their diets and lose weight. In the past several years, however, researchers and clinicians have observed that body weight returns to pretreatment levels when the medication is discontinued. Consequently, they have largely agreed that for weight reduction drugs to be effective, people must take them chronically, perhaps for a lifetime.

To determine just how much weight people could expect to lose if they took Redux or a similar drug for a long time, Levitsky analyzed the studies from all the articles published in scientific, peer-reviewed journals in which patients remained on fenfluramine for more than three months. His analysis is published in the January/February issue of Healthy Weight Journal, a publication intended for professional dietitians and clinical weight loss personnel.


'"/>

Contact: Susan Lang
SSL4@cornell.edu
607-255-3613
Cornell University News Service
8-Jan-1997


Page: 1 2 3

Related medicine news :

1. Benefits of lung cancer screening with CT questioned
2. Benefits of screening for lung cancer with CT are not proven
3. Benefits of treating behavioral, functional problems caused by Alzheimers disease
4. Benefits of discussing teenage health concerns are small but encouraging
5. Benefits of exercise lead to further activity in elderly
6. UI Researcher Shows Economic Benefits Of Hospitals Fast-Tracking Patients Vary
7. UK Researchers Receive Grants To Examine Benefits Of Aerobic Exercise For People With Spinal Cord Injuries
8. Fetal Cell Therapy Benefits Some Parkinsons Patients
9. Study Finds Combining Exercise With Male Hormone Therapy Benefits Men With HIV-Wasting Disease
10. Postmenopausal Women Reap Heart Benefits From Foods Containing Vitamin E
11. Health Benefits Of Fitness

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Benefits New Diet Drug Don Outweigh Risks

(Date:5/23/2013)... high-risk neuroblastoma a common tumor that forms in the ... drugs. A study published by Cell Press in the ... reveals a new genomic approach to screen for compounds ... to differentiate, or convert from immature cells to more ... identified a compound that causes neuroblastoma cells to differentiate, ...
(Date:5/23/2013)... 2013 Sika Sarnafil , the ... today announced Imperial Roof Systems of Iowa as the ... dedication to quality during the re-roofing of the SuperTarget ... a Sika Sarnafil Elite contractor and one of Target’s ... is committed to sustainable building practices and they are ...
(Date:5/23/2013)... 23, 2013 Diabetes is one of ... become a nuisance when patients are unfortunate enough to ... the National Diabetes Information Clearinghouse at http://goo.gl/QyhCz , ... risk of developing neuropathy which further shrivels the nervous ... such patients. Such nerve damage affects the whole body ...
(Date:5/23/2013)... May 23, 2013 Professional Insurance Plans, ... the nation to celebrate Fibromyalgia Education and Awareness Month. ... chiropractors across the country, the agency feels that it ... of this syndrome that affects an estimated 10 million ... Association , the definition of Fibromyalgia (FM) is, “a ...
(Date:5/23/2013)... 2013 Retül University , the ... announce the formation of a strategic educational partnership with ... to offer a bike industry first “Positioned for Speed” ... for time trial, road and triathlon bike fit. , ... bike fitters with a Retül University, F.I.S.T. or S.I.C.I ...
Breaking Medicine News(10 mins):Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3
(Date:5/23/2013)... , May 23, 2013 Isis Pharmaceuticals, Inc. ... today announced that management will present a company overview at ... Conference on Thursday, May 30, 2013 at 8:40 a.m. ET ... live audio webcast of the presentation will be available on ... www.isispharm.com .  A replay will be available on the ...
(Date:5/23/2013)... TUCSON, Ariz. , May 23, 2013 ... world,s first and only FDA, Health Canada and CE ... announced today that the Glasgow Science Centre in ... visitors annually, is featuring the SynCardia temporary Total ... as part of its $3 million Bodyworks Exhibition, one ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
Cached News: